Skip Navigation

European Heart Journal 1999 20(23):1693-1700; doi:10.1053/euhj.1999.1549
Copyright © 1999 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (30)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gunn, J
Right arrow Articles by Cumberland, D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gunn, J
Right arrow Articles by Cumberland, D
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Review

Stent coatings and local drug delivery. State of the art

J Gunnf1 and D Cumberland

Section of Interventional Cardiology, University of Sheffield, Sheffield, U.K.

f1 Correspondence: Dr Julian Gunn, Lecturer/Hon. Senior Registrar in Cardiology, Department Cardiology, Clinical Sciences Building, Northern General Hospital, Herries Road, Sheffield S5 7AU, U.K.

References

  1. Gunn J, Malik N, Shepherd L. In-stent restenosis: more metal and more symmetry required? (Abstr). Heart. 1997;77:46[Abstract/Free Full Text]
  2. Bier JD, Zalesky P, Li ST. A new bioabsorbable intravascular stent: in vitro assessment of hemodynamic and morphometric characteristics. J Interven Cardiol. 1992;5:187–194[ISI][Medline]
  3. van der Giessen WJ, Slager CJ, Beusekom HMM. Development of a polymer endovascular prosthesis and its implantation in porcine arteries. J Interven Cardiol. 1992;5:175–185[ISI][Medline]
  4. Murphy JG, Schwartz RS, Edwards WD. Percutaneous polymeric stents in porcine coronary arteries. Initial experience with polyethylene terephthalate stents. Circulation. 1992;86:1596–1604[Abstract/Free Full Text]
  5. Wilczek KL, de Scheerder IK, Kai W. Comparison of intra-vascular compatibility of polyethylene terephthalate self-expanding stents with Wallstents (Abstr). Eur Heart J. 1995;16:177[Abstract/Free Full Text]
  6. van der Giessen W, van Beusekom HM, Hofma SH. Preliminary results with bi-component metal-biodegradable polymer stents in porcine coronary mode (Abstr). Eur Heart J. 1996;17:178
  7. de Scheerder IK, Wilczik KL, Verbeken EV. Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries. Atherosclerosis. 1995;114:105–114[CrossRef][ISI][Medline]
  8. Rechavia E, Fishbein MC, DeFrance T. Vascular injury triggered by temporary and permanently implanted polyurethane coated and uncoated stents in rabbit carotid arteries (Abstr). Circulation. 1996;94:I88
  9. Rogers C, Tseng DY, Gingras PH. Expanded polytetra fluoroethylene stent graft encapsulation reduces intimal thickening regardless of stent design (Abstr). J Am Coll Cardiol. 1998;31:413A
  10. Chronos NAF, Robinson KA, Kelly AB. Thromboresistant phosphorylcholine coating for coronary stents (Abstr). Circulation. 1995;92:685
  11. Malik N, Gunn J, Shepherd L. Phosphorylcholine coated stents in porcine coronary arteries: angiographic and morphometric assessment (Abstr). Eur Heart J. 1997;18:152
  12. Kuiper KK, Robinson KA, Chronos NAF. Implantation of metal phosphorylcholine coated stents in rabbit iliac and porcine coronary arteries (Abstr). Circulation. 1997;96:21
  13. van Beusekom HMM, Whelan DM, Krabbendam SC. Biocompatibility of phosphorylcholine coated stents in a porcine coronary artery model (Abstr). Circulation. 1997;96:21
  14. Malik N, Gunn J, Newman C. Phosphorylcholine-coated stents: angiographic and morphometric assessment in porcine coronary arteries (Abstr). J Am Coll Cardiol. 1998;31:414A
  15. Cumberland, DC, Bonnier, H, Colombo, A, Initial clinical experience with the phosphorylcholine coated divYsio stent
  16. Serruys PW, van Hout B, Bonnier H. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet. 1998;352:673–681[CrossRef][ISI][Medline]
  17. Lopez A, Heuser RR, Stoerger H. Coronary artery application of an endoluminal polytetrafluoroethylene stent graft: two center experience with the JoMed Jo Stent (Abstr). Circulation. 1998;17:855
  18. Morice MC, Louvard Y, Buchard L. French registry of coronary stent grafts. Acute and mid-term results (Abstr). Circulation. 1998;17:855
  19. Landau C, Willard JE, Clagett GP. Biodegradable stents function as vehicles for vascular delivery or recombinant adenovirus vectors (Abstr). Circulation. 1995;92:670
  20. Voisard R, Alt E, Baur R. Paclitaxel-coated biodegradable stents inhibit proliferative activity and severely damage cytoskeletal components of smooth muscle cells from human coronary plaque material in vitro (Abstr). Eur Heart J. 1998;19:376
  21. Serruys PW, Emanuelson H, van der Giessen W. Heparin coated Palmaz Schatz stents in human coronary arteries. Circulation. 1996;93:412–422[Abstract/Free Full Text]
  22. Guagliumi G, Valsecchi O, Tespili M. How do heparin coated stents perform in the real world: a randomised comparison with uncoated stents in unselected native coronary lesions (Abstr). Eur Heart J. 1997;18:623
  23. Vrolix MC, Grollier G, Legrand V. Heparin coated wire coil (Wiktor) for elective stent placement: the MENTOR trial (Abstr). Eur Heart J. 1997;18:155
  24. Serruys PW, Garcia-Fernandez E, Kiemeneij F. Heparin coated stent in acute myocardial infarction: a pilot study as preamble to a large randomised trial comparing balloon angioplasty and stenting. Eur Heart J. 1997;18:272
  25. De Scheerder I, Wang K, Wilczek K. Experimental study of thrombogenicity and foreign body reaction induced by heparin-coated coronary stents. Circulation. 1997;95:1549–1553[Abstract/Free Full Text]
  26. Rogers C, Kjelsberg MA, Seifert P. Heparin-coated stents eliminate mural thrombus deposition for days without affecting restenosis (Abstr). Circulation. 1997;96:710
  27. Kocsis JF, Lunn AC, Mohammed SF. Incomplete expansion of coronary stents: risk of thrombogenesis and protection provided by a heparin coating (Abstr). Eur Heart J. 1997;18:137
  28. Chronos NAF, Robinson KA, King SB. Heparin coated Palmaz–Schatz stents are highly thrombo-resistant: a baboon AV shunt study (Abstr). J Am Coll Cardiol. 1996;27:84A
  29. Gao R, Shi R, Qiao S. A novel polymeric local heparin delivery stent: initial experimental study (Abstr). J Am Coll Cardiol. 1996;27:85–86A
  30. Chronos NAF, Robinson KA, White D. Heparin coating dramatically reduces platelet deposition on incompletely deployed Palmaz–Schatz stents in the baboon AV shunt (Abstr). J Am Coll Cardiol. 1996;27:84A
  31. Chronos NAF, Robinson KA, Kelly AB. Neointima formation in stented baboon carotid arteries is reduced by bonded heparin: correlation with decreased thrombogenicity (Abstr). J Am Coll Cardiol. 1996;27:85A
  32. Hermann R, Schmidmaier G, Alt E. Comparison of the thrombogenicity of steel and gold-surface coronary stents with a biodegradable, drug-releasing coating in a human stasis model (Abstr). Eur Heart J. 1997;18:152
  33. Schmidmaier G, Stemberger A, Alt E. Non-linear time release characteristics of a biodegradable polylactic acid stent coating releasing PEG-hirudin and a PG12 analog (Abstr). Eur Heart J. 1997;18:571
  34. Alt E, Beilharz C, Preter D. Biodegradable stent coating with polylactic acid, hirudin and prostacyclin reduces restenosis. J Am Coll Cardiol. 1997;29:238A
  35. Baron JH, Aggarwal R, de Bono D. Adsorption and elution of c7E3 Fab from polymer-coated stents in vitro (Abstr). Eur Heart J. 1997;18:503[Abstract/Free Full Text]
  36. Baron JH, Aggarwal RK, Azrin M. Development of c7E3 Fab (abciximab) eluting stents for local drug delivery: effect of sterilization and storage (Abstr). Circulation. 1998;17:855
  37. Baron JH, Aggarwal RK, de Bono DP. Polymer coated stents eluting c7E3 Fab (abciximab) inhibit platelet deposition in vitro (Abstr). Eur Heart J. 1998;19:496
  38. Aggarwal RK, Ireland DC, Ragheb A. Adsorption and elution kinetics and antithrombotic efficacy of antiplatelet GPIIbIIIa antibody and urokinase bonded to polymer-coated stent wire (Abstr). Eur Heart J. 1995;16:360[Abstract/Free Full Text]
  39. Tanguay JF, Santos RM, Kruse KR. Local delivery of a potent GPIIbIIIa inhibitor using a composite polymeric stent reduces platelet deposition (Abstr). Eur Heart J. 1995;16:454
  40. Aggarwal RK, Ireland DC, Azrin MA. Antithrombotic potential of polymer-coated stents eluting platelet glycoprotein IIb/IIIa receptor antibody. Circulation. 1996;94:3311–3317[Abstract/Free Full Text]
  41. Aggarwal RK, Ireland DC, Ragheb A. Reduction in thrombogenicity of polymer-coated stents by immobilization of platelet-targeted urokinase (Abstr). Eur Heart J. 1996;17:177
  42. Emanuelsson H, Beatt KJ, Bagger JP. Long term effects of angiopeptin treatment in coronary angioplasty: reduction of clinical events but not angiographic restenosis. Circulation. 1995;91:1689–1696[Abstract/Free Full Text]
  43. Eriksen UH, Amtorp O, Bagger JP. A randomised Scandinavian trial of angiopeptin versus placebo for the prevention of restenosis after coronary balloon angioplasty. Am Heart J. 1995;130:1–8[CrossRef][ISI][Medline]
  44. Hung MK, Kent KM, Mehran R. Continuous subcutaneous angiopeptin treatment significantly reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model. Circulation. 1997;95:449–454[Abstract/Free Full Text]
  45. de Scheerder IK, Wilczie K, van Dorpe J. Local angiopeptin delivery using coated stents reduces neointimal proliferation in overstretched porcine coronary arteries. J Invas Cardiol. 1996;8:215–222[ISI][Medline]
  46. Armstrong, J, Holt, CM, Gunn, J, Local drug delivery from coronary stents in the porcine coronary artery, Heart
  47. Lincoff AM, Furst JG, Ellis SG. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. J Am Coll Cardiol. 1997;29:808–816[Abstract]
  48. de Scheerder IK, Kai W, van Dorpe J. Methylprednisolone loaded stents inhibit the neointimal reaction induced by polymer coated stents implanted in porcine coronary arteries (Abstr). Circulation. 1995;92:87
  49. Yamawaki T, Shimokawa H, Kozai T. Intraluminal delivery of tyrosine kinase inhibitor with biodegradable stent suppresses the restenostic changes of the coronary artery in pigs (Abstr). Circulation. 1997;96:608
  50. Kornowski R, Hong MK, Ragheb AO. Slow release Taxol-coated GRII stents reduce neointima formation in a porcine coronary in-stent restenosis model (Abstr). Circulation. 1997;96:341
  51. Farb A, Heller PF, Carter AJ. Paclitaxel polymer-coated stents reduce neointima (Abstr). Circulation. 1997;96:608
  52. Folts JD, Maalej N, Keaney JF. Coating Palmaz–Schatz stents with a unique NO donor renders them much less thrombogenic when placed in pig carotid arteries (Abstr). Circulation. 1995;92:670
  53. Foo RS, Hogrefe K, Baron JH. Activated protein C elution from stent wires: a future non-thrombogenic stent (Abstr). Eur Heart J. 1998;19:499
  54. Rogers C, Edelman ER. Controlled release of heparin reduces neointimal hyperplasia in stented rabbit arteries. J Interven Cardiol. 1992;5:195–202
  55. Wilensky RL, Tanguay JFL, Ito S. The heparin infusion prior to stenting trial (HIPS): procedural, in-hospital, 30-day, and 6-month clinical, angiographic and IVUS results (Abstr). Eur Heart J. 1998;19:49
  56. Bartorelli AL, De Cesare NB, Kaplan AV. Local heparin delivery prior to coronary stent implantation: acute and six month clinical and angiographic results. Cathet Cardiovasc Diagn. 1997;42:313–320[CrossRef][ISI][Medline]
  57. Gregoire J, Jeong MH, Camrud AR. Does local iontophoretic low molecular weight heparin delivery reduce neointimal formation after stenting? (Abstr). J Am Coll Cardiol. 1997;29:238A
  58. Kiesz RS, Buszman P, Deutsch E. Local delivery of enoxaparin prior to NIR stent placement may reduce late luminal loss. Long term results of POLONIA study (Abstr). Circulation. 1998;17:433
  59. Reimers B, Akiyama T, Moussa I. Persistent high restenosis after local delivery of long acting steroids prior to coronary stent implantation (Abstr). Circulation. 1997;96:710–711
  60. Kutryk, MJB, The ITALICS study, 1998
  61. Hong MK, Kent KM, Mehran R. Continuous subcutaneous angiopeptin treatment significantly reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model. Circulation. 1997;95:449–454
  62. Baumbach A, Lerch M, Oberhoff M. Local delivery of paclitaxel following stent implantation in the porcine coronary artery (Abstr). Eur Heart J. 1998;19:496
  63. van Belle E, Tio FO, Chen D. Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening. J Am Coll Cardiol. 1997;29:1371–1379[Abstract]
  64. Bailey SR, Decento YJ, Sprague E. Endothelial sodding: intraprocedural replacement of endothelial cells on endovascular stents (Abstr). Circulation. 1996;94:261
  65. Biocompatibles Ltd, 1998
  66. Gunn J, Malik N, Chico T. Vascular injury after local drug delivery is dependent upon the volume infused (Abstr). Eur Heart J. 1998;19:496
  67. Toutouzas K, Stefanadis C, Vlachopoulos C. Autologous vein graft-coated stent: a comparative experimental study with conventional stenting (Abstr). Eur Heart J. 1995;16:178
  68. Stefanadis C, Toutouzas K, Vlachopoulos C. Coronary stenting using the autologous vein graft-coated stent: the early clinical experience. Eur Heart J. 1995;16:412
  69. Toutouzas K, Stefanadis C, Tsiamis E. Effects of stents coated by an autologous vein graft on intimal hyperplasia in porcine coronary arteries (Abstr). J Am Coll Cardiol. 1998;31:414A
  70. Toutouzas K, Stefanadis C, Tsiamis E. Autologous vein-graft covered stent for the treatment of coronary artery disease: immediate and long-term results (Abstr). Eur Heart J. 1998;19:498
  71. Toutouzas KP, Stefanadis CI, Tsiamis KG. Stents covered by an autologous vein graft: retrospective comparative study with conventional uncovered stents (Abstr). Circulation. 1998;17:855
  72. Muramatsu T, Tsukahara R, Hou M. Clinical evaluation of vessel remodelling after vein-covered stent implantation evaluated by intravascular ultrasound (Abstr). Eur Heart J. 1998;19:497
  73. Toutouzas K, Stefanadis C, Tsiamis E. Coating of stents by autologous vascular grafts reduces the extent of vascular injury in porcine coronary arteries (Abstr). J Am Coll Cardiol. 1998;31:414A
  74. Holmes DR, Camrud AR, Jorgenson MA. Polymeric stenting in the porcine coronary artery model: differential outcome of exogenous fibrin sleeves versus polyurethane-coated stents. J Am Coll Cardiol. 1994;24:525–531[Abstract]
  75. McKenna CJ, Camrud AR, Wolff R. Fibrin film stenting in a porcine coronary injury model: efficacy and safety compared to uncoated stents (Abstr). Circulation. 1997;96:15[Abstract/Free Full Text]
  76. Baker JE, Nikolaychik V, Zulich A. Fibrin coated stents as a depot to deliver RGD peptide inhibit vascular reaction in atherosclerotic rabbit model (Abstr). J Am Coll Cardiol. 1996;27:197A
  77. Monnink SHJ, Tigchelaar I, van Boven AJ. Biocompatibility of the silicon-carbide coated Biotronik stent. Circulation. 1998;17:856
  78. Unverdorben M, Schywalsky M, Labahn D. A new silicon carbide coated stent-experience in the rabbit (Abstr). Eur Heart J. 1996;17:178
  79. Bolz A, Amon M, Ozbek C. Coating of cardiovascular stents with a semi-conductor to improve their hemocompatibility. Tex Heart Inst J. 1996;23:162–166[ISI][Medline]
  80. Heublein B, Pethig K, Elsayed AM. Silicon carbide coating—a semi-conducting hybrid design of coronary stents—feasibility study. J Invas Cardiol. 1998;10:255–262[ISI][Medline]
  81. Beythien C, Gutensohn K, Kenner T. Diamond-like carbon coating of coronary stents: influence on platelet activation, smooth muscle cells and release of metal atoms (Abstr). Eur Heart J. 1998;19:497
  82. Beythien C, Gutensohn K, Kuhnl P. Influence of ‘diamond-like’ and gold coating on platelet activation: a flow cytometry analysis in a pulsed floating model (Abstr). J Am Coll Cardiol. 1998;31:413A
  83. Herrmann RA, Rybnikar A, Resch A. Thrombogenicity of stainless steel coronary stents with a completely gold coated surface. J Am Coll Cardiol. 1998;31:413A
  84. Schomig A, Kastrati A, Neumann FJ. Impact of gold plating on the outcome after coronary stent placement: results of randomised trial. Circulation. 1998;17:855

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Journal of Pharmacy PracticeHome page
W. Alvarez Jr and N. K. Kapur
Drug Eluting Stent Technology: A Paradigm Shift in the Treatment and Prevention of Restenosis
Journal of Pharmacy Practice, December 1, 2005; 18(6): 461 - 478.
[Abstract] [PDF]

Home page
 J Am Coll CardiolHome page
H. C. Lowe, S. N. Oesterle, and L. M. Khachigian
Coronary in-stent restenosis: Current status and future strategies
J. Am. Coll. Cardiol., January 16, 2002; 39(2): 183 - 193.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
J Wohrle, E Al-Khayer, U Grotzinger, C Schindler, M Kochs, V Hombach, and M Hoher
Comparison of the heparin coated vs the uncoated Jostent(R)--no influence on restenosis or clinical outcome
Eur. Heart J., October 1, 2001; 22(19): 1808 - 1816.
[Abstract] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
I. Fishbein, M. Chorny, S. Banai, A. Levitzki, H. D. Danenberg, J. Gao, X. Chen, E. Moerman, I. Gati, V. Goldwasser, et al.
Formulation and Delivery Mode Affect Disposition and Activity of Tyrphostin-Loaded Nanoparticles in the Rat Carotid Model
Arterioscler. Thromb. Vasc. Biol., September 1, 2001; 21(9): 1434 - 1439.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (30)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gunn, J
Right arrow Articles by Cumberland, D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gunn, J
Right arrow Articles by Cumberland, D
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?